Danaher Corporation (NYSE:DHR) Receives Average Rating of “Moderate Buy” from Brokerages

Posted by Stanley Muller on Sep 22nd, 2026

Shares of Danaher Corporation (NYSE:DHR – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-four analysts that are currently covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $229.3182.

A number of research firms have recently weighed in on DHR. DZ Bank began coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. Weiss Ratings upgraded Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Piper Sandler initiated coverage on Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective on the stock. Finally, Evercore restated an “outperform” rating and set a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th.

View Our Latest Stock Report on DHR

Danaher Stock Up 2.0%

Shares of DHR opened at $216.12 on Tuesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock has a market capitalization of $151.93 billion, a price-to-earnings ratio of 38.39, a price-to-earnings-growth ratio of 2.64 and a beta of 0.78. Danaher has a 1 year low of $160.93 and a 1 year high of $242.80. The business’s 50 day simple moving average is $204.40 and its 200-day simple moving average is $192.04.

Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period last year, the firm posted $0.77 earnings per share. As a group, equities analysts expect that Danaher will post 8.53 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s payout ratio is currently 28.42%.

Institutional Trading of Danaher

A number of institutional investors have recently bought and sold shares of the stock. BlackRock Inc. purchased a new stake in shares of Danaher in the second quarter valued at $10,492,520,000. State Street Corp boosted its stake in shares of Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after purchasing an additional 472,608 shares during the period. Capital International Investors grew its holdings in Danaher by 8.9% during the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after purchasing an additional 1,487,768 shares during the last quarter. Wellington Management Group LLP grew its holdings in Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after purchasing an additional 1,542,310 shares during the last quarter. Finally, Norges Bank purchased a new stake in Danaher in the 4th quarter worth about $2,177,106,000. 79.05% of the stock is currently owned by institutional investors.

About Danaher

(Get Free Report)

Danaher Corporation (NYSE:DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its businesses support pharmaceutical and biotechnology research, biomanufacturing, clinical laboratories and healthcare providers.

The company’s portfolio includes bioprocessing technologies, laboratory instruments, consumables, reagents and software. Key businesses include Cytiva, which provides biomanufacturing solutions; Beckman Coulter, which supplies laboratory diagnostics and automation systems; Leica Biosystems, which develops pathology products; and IDT, which provides genomic and nucleic acid products.